FindTrial
Sign In

VALUTATION OF PLACEBO EFFECT AFTER CONDITIONING WITH APOMORPHINE AND WITHOUT PHARMACOLOGICAL CONDITIONING ON THE RIGIDITY AND ELECTRICAL ACTIVITY OF NEURONS OF SUBTHALAMIC NUCLEUS IN PARKINSON PATIENTS.

VALUTATION OF PLACEBO EFFECT AFTER CONDITIONING WITH APOMORPHINE AND WITHOUT PHARMACOLOGICAL CONDITIONING ON THE RIGIDITY AND ELECTRICAL ACTIVITY OF NEURONS OF SUBTHALAMIC NUCLEUS IN PARKINSON PATIENTS.

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
EU CTR
Registry ID
EUCTR2005-000431-22-IT
Enrollment
Unknown
Registered
2005-09-02
Start date
2005-03-10
Completion date
Unknown
Last updated
2012-03-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

THE TOPICAL INVESTIGATION IS THE BASE OF PATOLOGY MedDRA version: 6.1 Level: PT Classification code 10061536

Interventions

Trade Name: APOFIN STYLO*1 PENNA 3ML 1% Pharmaceutical Form: Solution for injection INN or Proposed INN: Apomorphine CAS Number: 47372-20-7 Concentration unit: mg milligram(s) Concentration type: equa

Sponsors

AZIENDA SANITARIA OSPEDALIERA "S. GIOVANNI BATTISTA DI TORINO"
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Are the trial subjects under 18? no Number of subjects for this age range: F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range F.1.3 Elderly (>=65 years) yes F.1.3.1 Number of subjects for this age range

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Main Objective: ;Secondary Objective: ;Primary end point(s):—

Countries

Italy

Outcome results

None listed

Source: EU CTR (via WHO ICTRP) · Data processed: Feb 4, 2026